via University of Wisconsin–Madison
Like the hardiest weed, glioblastoma almost always springs back — usually within months after a patient’s initial brain tumor is surgically removed. That is why survival rates for this cancer are just 25 percent at one year and plummet to 5 percent by the five-year mark.
One of the challenges of treating this disease is that surgeons can’t always remove every bit of tumor or glioma stem cells that might linger in the brain.
“One characteristic of glioblastoma is that the tumor cells are very aggressive, and they will infiltrate the surrounding tissues. So the surgeon can’t clearly feel the boundaries between the tumor and the normal tissue, and you cannot remove as much as possible because all the tissues in the brain are extremely important — you certainly don’t want to remove too much,” explains Quanyin Hu, an assistant professor in the University of Wisconsin–Madison School of Pharmacy’s Pharmaceutical Sciences Division. “So the tumor will come back again, and that sharply decreases the survival rate after treatment.”
But Hu’s Cell-Inspired Personalized Therapeutic (CIPT) Lab has developed a powerful immunity-boosting postoperative treatment that could transform the odds for patients with glioblastoma. Hu and his collaborators published their research on the treatment’s use in mouse models of human glioblastoma this month in the journal Science Translational Medicine.
“It provides hope for preventing glioblastoma relapse,” Hu says. “We prove that it can actually eradicate these glioma stem cells, which can eventually prevent the glioblastoma from coming back. We can significantly improve survival.”
Hu’s lab developed a hydrogel that can be injected into the brain cavity left behind by the excised tumor. The hydrogel delivery method works well because it completely fills the brain cavity, slowly releases the medicine into the surrounding tissue, and promotes the cancer-killing immune response, Hu notes.
“We have a lot of work to do before it can be potentially translated into the clinic, but we feel confident that this is a very promising approach for bringing new hope to patients with glioblastoma so they can recover after surgery.”
The hydrogel is packed with nanoparticles designed to enter and reprogram certain types of immune cells called macrophages. These immune cells normally clean up infectious invaders in the body, but in the tumor environment, they can change into a form that instead suppresses the immune system and promotes cancer growth. And because of the inflammation created by surgery, these rogue macrophages flock to the surgical site, potentially fueling cancer relapse.
“We want to take advantage of these macrophages and turn them from enemy to ally,” Hu says.
To do that, the nanoparticles can engineer the macrophages to target a glycoprotein called CD133, a marker for cancer stem cells. Hu’s team also added an antibody, CD47, that blocks a “don’t-eat-me” signal to promote macrophages to recognize the cancer cells. The preclinical results in mice models show that the hydrogel treatment successfully generated glioma stem cell-specific chimeric antigen receptor (CAR) macrophages — essentially engineering the immune cells on site to target and kill any lingering glioma stem cells.
If effective in humans, the hydrogel treatment could eliminate the need for postsurgical chemotherapy or radiation, reducing toxic side effects while also improving patient outcomes.
Hu’s next step is testing the hydrogel in larger animal models and also monitoring long-term efficacy and toxicity beyond the four- to six-month period he previously studied.
“We have a lot of work to do before it can be potentially translated into the clinic, but we feel confident that this is a very promising approach for bringing new hope to patients with glioblastoma so they can recover after surgery,” Hu says. “We hope we can do our work to be able to advance this technology to the clinic.”
While Hu’s team is initially focused on glioblastoma, the treatment approach could also be applied to other aggressive solid tumors, including breast cancer, he notes. “Our approach is taking advantage of the macrophages in the postsurgical areas and to locally engineer these macrophages,” he says. “In this scenario, we can confidently say that it will apply to the majority of solid tumors with high invasive characteristics.”
Original Article: New injectable gel offers promise for tough-to-treat brain tumors
More from: University of Wisconsin-Madison
The Latest Updates from Bing News
Go deeper with Bing News on:
Immunity-boosting postoperative treatment
- Prevention and Treatment of Postoperative Nausea and Vomiting
near the end of surgery for preventing postoperative nausea and vomiting has not been sufficiently studied. d Children who weigh >10 kg or who are at least two years of age only. Change from ...
- Want to Give Your Immune System a Boost? Load Up On These 25 Vitamin C-Packed Foods
A n apple a day may keep the doctor away, but adding in some vitamin C to your diet for good measure will help, too. Vitamin C, also known as ascorbic acid, supports the immune system and helps your ...
- Here’s Why Mushroom Supplements Are Now Part of Our Everyday Routine
Lion’s Mane: One of the most potent medicinal mushrooms, Lion’s Mane has a range of benefits from inflammation reduction to immunity-boosting and anxiety treatment. Cordyceps: Cordyceps fungus ...
- Home Remedies: 6 Herbal Drinks To Boost Immunity
indirectly supporting your immunity. Garlic is known for its antimicrobial properties, while honey soothes the throat. Mixing crushed garlic with honey makes a potent immune-boosting tonic.
- 5 Immunity-Boosting Smoothie Recipes
This article is based on reporting that features expert sources. Immunity-Boosting Smoothie Recipes Smoothies have become a hugely popular way for folks to pack a little extra nutrition into a ...
Go deeper with Bing News on:
Hydrogel delivery method
- Innovative double-layer polysaccharide hydrogel revolutionizes intestine-targeted oral delivery of probiotics
In a groundbreaking study, a research team led by Changhu Xue and Xiangzhao Mao from the Ocean University of China has developed a remarkable double-layer polysaccharide hydrogel (DPH) that promises ...
- Could this new hydrogel make HIV therapy more convenient?
A new injectable solution that self-assembles into a gel under the right conditions could help manage HIV unlike any currently available methods, Johns Hopkins researchers have found ...
- Hydrogel Delivery Balances Tumor’s pH, Boosts Cancer Drug’s Activity
A new hydrogel-based delivery system balances the acidic environment in a tumor and greatly enhances the cancer-fighting activity of chemotherapeutic drug.
- Drug Delivery System May Boost Effects of Anti-Cancer Drug
“What we’re trying to do is to develop a method to locally deliver doxorubicin but also mitigate acidosis at the same time,” Ahmed said. “To do this, we created an injectable hydrogel where we ...
- Tattooing Gold on Live Cells for Smart Device Integration
The technology advances previous work that used hydrogels to stick nanotechnology onto human skin ... high-resolution, lithographic method to attach nanomaterials to living tissue and cells. They used ...